Indications and uses
For the temporary relief of burning, irritation and discomfort due to dryness of the eye or exposure to wind or sun. May be used as a protectant against further irritation or to relieve dryness of the eye.
For the temporary relief of burning, irritation and discomfort due to dryness of the eye or exposure to wind or sun. May be used as a protectant against further irritation or to relieve dryness of the eye.
To open, twist and pull tab to remove. Instill 1 or 2 drops in the affected eye(s) as needed or as directed by your eyecare professional.
Polyethylene Glycol 400 0.25%
Eye lubricant
You experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.
If swallowed, get medical help or contact a Poison Control Center right away.
Boric Acid, Calcium Chloride, Magnesium Chloride, Potassium Chloride, Purified Water, Sodium Borate, Sodium Chloride, Sodium Hyaluronate.
In the U.S. call 1-800-347-5005
1 packer = 36 strips (180 vials)
Professional use - Not for resale
THIS SIDE UP
No. 94153
Store away from heat
Protect from freezing
Blink
®Tears Lubricating Eye Drops
0.01 fl oz (0.4 mL)
40171-00536
Product of Germany
Blink is a trademark of
Johnson & Johnson
Surgical Vision, Inc.
© Johnson & Johnson Surgical Vision, Inc. 2023
Johnson & Johnson Surgical Vision, Inc.
Irvine, CA 92618 U.S.A.
1-800-347-5005

| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1094102 | blink Tears 0.25 % Ophthalmic Solution | PSN | 10 |
| 853238 | polyethylene glycol 400 0.25 % Ophthalmic Solution | PSN | 10 |
| 1094102 | polyethylene glycol 400 2.5 MG/ML Ophthalmic Solution [Blink Tears] | SBD | 10 |
| 853238 | polyethylene glycol 400 2.5 MG/ML Ophthalmic Solution | SCD | 10 |
| 1094102 | Blink Tears 0.25 % Lubricating Eye Drops | SY | 10 |
| 1094102 | Blink Tears 2.5 MG/ML Ophthalmic Solution | SY | 10 |
| 853238 | PEG-400 0.25 % Ophthalmic Solution | SY | 10 |
| 853238 | polyethylene glycol 400 0.25 % Ophthalmic Solution | SY | 10 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 40171-005-05 | blink tears | 0.4 mL in 1 VIAL, SINGLE-USE | SOLUTION/ DROPS | 0.4 | 10 | |
| 40171-005-05 | blink tears | 5 in 1 CARTON | SOLUTION/ DROPS | 5 | 10 | |
| 40171-005-25 | blink tears | 0.4 mL in 1 VIAL, SINGLE-USE | SOLUTION/ DROPS | 0.4 | 10 | |
| 40171-005-25 | blink tears | 25 in 1 CARTON | SOLUTION/ DROPS | 25 | 10 | |
| 40171-005-36 | blink tears | 0.4 mL in 1 VIAL, SINGLE-USE | SOLUTION/ DROPS | 0.4 | 10 | |
| 40171-005-36 | blink tears | 180 in 1 CARTON | SOLUTION/ DROPS | 180 | 10 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Polyethylene Glycol 400 | ACTIVE INGREDIENT | B697894SGQ | 1 | |
| Polyethylene Glycol 400 | ACTIVE MOIETY | B697894SGQ | 1 | |
| Boric Acid | INACTIVE INGREDIENT | R57ZHV85D4 | 1 | |
| Calcium Chloride | INACTIVE INGREDIENT | M4I0D6VV5M | 1 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| Magnesium Chloride | INACTIVE INGREDIENT | 02F3473H9O | 1 | |
| Potassium Chloride | INACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| SODIUM BORATE | INACTIVE INGREDIENT | 91MBZ8H3QO | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| SODIUM CHLORITE | INACTIVE INGREDIENT | G538EBV4VF | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 40171-005 | 40171-005-05, 40171-005-25, 40171-005-36 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BORIC ACID | R57ZHV85D4 | IACT |
| CALCIUM CHLORIDE | M4I0D6VV5M | IACT |
| MAGNESIUM CHLORIDE | 02F3473H9O | IACT |
| POTASSIUM CHLORIDE | 660YQ98I10 | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BORATE | 91MBZ8H3QO | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| HYALURONATE SODIUM | YSE9PPT4TH | IACT |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Potassium Chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| SODIUM BORATE | SODIUM BORATE | 91MBZ8H3QO | SOLUTION/ DROPS / OPHTHALMIC | 1.1 %w/v | ||
| Magnesium Chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| SODIUM CHLORITE | SODIUM CHLORITE | G538EBV4VF | SOLUTION/ DROPS / OPHTHALMIC | 0.01 %w/v | ||
| Magnesium Chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| SODIUM CHLORITE | SODIUM CHLORITE | G538EBV4VF | SOLUTION/ DROPS / OPHTHALMIC | 0.01 %w/v | ||
| SODIUM CHLORITE | SODIUM CHLORITE | G538EBV4VF | SOLUTION/ DROPS / OPHTHALMIC | 0.01 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| Magnesium Chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| Calcium Chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | GEL / TOPICAL | 463 mg | ||
| Calcium Chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| Potassium Chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| SODIUM BORATE | SODIUM BORATE | 91MBZ8H3QO | SOLUTION/ DROPS / OPHTHALMIC | 1.1 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| Calcium Chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg | ||
| Potassium Chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| Magnesium Chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| Boric Acid | BORIC ACID | R57ZHV85D4 | SOLUTION/ DROPS / OPHTHALMIC | 48 mg | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| Calcium Chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | GEL / TOPICAL | 463 mg | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| Boric Acid | BORIC ACID | R57ZHV85D4 | SOLUTION/ DROPS / OPHTHALMIC | 48 mg | ||
| SODIUM BORATE | SODIUM BORATE | 91MBZ8H3QO | SOLUTION/ DROPS / OPHTHALMIC | 1.1 %w/v | ||
| Potassium Chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| SODIUM BORATE | SODIUM BORATE | 91MBZ8H3QO | SOLUTION/ DROPS / OPHTHALMIC | 1.1 %w/v | ||
| Boric Acid | BORIC ACID | R57ZHV85D4 | SOLUTION/ DROPS / OPHTHALMIC | 48 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | GEL / TOPICAL | 463 mg | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg | ||
| Boric Acid | BORIC ACID | R57ZHV85D4 | SOLUTION/ DROPS / OPHTHALMIC | 48 mg | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| SODIUM CHLORITE | SODIUM CHLORITE | G538EBV4VF | SOLUTION/ DROPS / OPHTHALMIC | 0.01 %w/v | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | GEL / TOPICAL | 463 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| blink tears | POLYETHYLENE GLYCOL 400 | Bausch & Lomb Incorporated | 10fcf407-6eaf-4730-9ed0-9b7715cf5701 | 2024-09-20 | Warnings | 40171-005-36 40171-005-05 40171-005-25 40171-005 40171000525 40171000505 40171000536 2298793e-fe31-cd2b-e063-6394a90ad92b 10fcf407-6eaf-4730-9ed0-9b7715cf5701 |
Adverse event summaries are temporarily unavailable. Other product information remains available.